Peter Sandner is a pharmacist by training, holds a PhD in Physiology from the University of Regensburg and is an appointed extraordinary professor for pharmacology at Hannover Medical School. Peter is working in Drug Discovery Research of Bayer AG, Pharmaceuticals at the Research Center at Wuppertal, Germany for almost 25 years and was nominated at Chief Scientist in 2016. Within Bayer Peter continued his academic research on cyclic nucleotides and cGMP by nonclinical profiling of cGMP-increasing therapeutic principles, especially phosphodiesterase inhibitors and stimulators and activators of sGC. He is responsible for the nonclinical research with sGC stimulators and sGC activators in various therapeutic areas.